A detailed history of Australian Super Pty LTD transactions in Dexcom Inc stock. As of the latest transaction made, Australian Super Pty LTD holds 15,725 shares of DXCM stock, worth $1.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,725
Previous 10,157 54.82%
Holding current value
$1.27 Million
Previous $1.15 Million 8.51%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$64.0 - $116.06 $356,352 - $646,222
5,568 Added 54.82%
15,725 $1.05 Million
Q3 2023

Oct 27, 2023

BUY
$86.06 - $137.93 $43,116 - $69,102
501 Added 5.19%
10,157 $947,000
Q2 2023

Jul 28, 2023

BUY
$112.47 - $130.98 $1.09 Million - $1.26 Million
9,656 New
9,656 $1.24 Million
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $1.58 Million - $1.87 Million
-16,570 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$62.68 - $105.34 $1.04 Million - $1.75 Million
16,570 New
16,570 $6.72 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Australian Super Pty LTD Portfolio

Follow Australian Super Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Australian Super Pty LTD with notifications on news.